Производные фуллерена как модуляторы процессов клеточной пролиферации и апоптоза

1. Duncan R., Gaspar R. Nanomedicine(s) under the microscope. Mol Pharmaceutics 2011;8:2101–41.

2. Harhaji L., Isakovic A., Raicevic N. et al. Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. Eur J Pharmacol 2007;568:89–98.

3. Dugan L.L., Turetsky D.M., Du C. et al. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci (USA) 1997;94:9434–9.

4. Monti D., Moretti L., Salvioli S. et al. C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem Biophys Res Commun 2000;277:711–7.

5. Dugan L.L., Gabrielsen J.K., Yu S.P. et al. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 1996;3:129–35.

6. Isakovic A., Markovic Z., Nikolic N. et al. Inactivation of nanocrystalline C60 cytotoxicity by γ-irradiation. Biomaterials 2006;27:5049–58.

7. Isakovic A., Markovic Z., Todorovic-Markovic B. et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 2006;91:173–83.

8. Yamawaki H., Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol 2006;290:C1495–C1502.

9. Yang X.L., Fan C.H., Zhu H.S. Photoinduced cytotoxicity of malonic acid [C60] fullerene derivatives and its mechanism. Toxicol in Vitro 2002;16:41–6.

10. Rancan F., Rosan S., Boehm F. et al. Cytotoxicity and photocytotoxicity of a dendritic C60 mono-adduct and a malonic acid C60 tris-adduct on Jurkat cells. J Photochem Photobiol B 2002;67:157–62.

11. Bosi S., Feruglio L., Da Ros T. et al. Hemolytic effects of water-soluble fullerene derivatives. J Med Chem 2004;47:6711–5.

12. Chen C., Xing G., Wang J. et al. Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett 2005;5(10):2050–7.

13. Darwish A.D. Fullerenes. Annu Rep Prog Chem A 2010;106:356–75.

14. Gao J., Wang H.L., Shreve A., Iyer R. Fullerene derivatives induce premature senescence: A new toxicity paradigm or novel biomedical applications. Toxicol Appl Pharmacol 2010;244:130–43.

15. Jung H., Wang C., Jang W. Nano-C60 and hydroxylated C60: Their impacts on the environment. Toxicol Envir Health Sci 2009;1:132–9.

16. Сидоров Л.Н., Юровская М.А., Борщевский А.Я. и др. Фуллерены. М.: Экзамен, 2005.

17. Hirsch A., Brettreich M. Fullerenes: chemistry and reactions. Weinheim, Wiley- VCH, 2005.

18. Пиотровский Л.Б., Киселев О.И. Фуллерены в биологии. СПб.: Росток, 2006.

19. Трошин П.А., Любовская З.Н. Органическая химия фуллеренов: основные реакции, типы соединений фуллеренов и перспективы их практического приме- нения. Успехи химии 2008;77:324–69.

20. Ema M., Kobayashi N., Naya M., Hanai S. et al. Reproductive and developmental toxicity studies of manufactured nanomaterials. J Reprod Toxicol 2010;30:343–52.

21. Markovic Z., Trajkovic V. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials 2008;29:3561–73.

22. Grausova L., Vacik J., Vorlicek V. et al. Fullerene C60 films of continuous and micropatterned morphology as substrates for adhesion and growth of bone cells. Diamond Relat Mater 2009;18:578–86.

23. Aschberger K., Johnston H.J., Stone V. et al. Review of fullerene toxicity andexposure – Appraisal of a human health risk assessment, based on open literature. Regul Toxicol Pharmacol 2010;58:455–73.

24. Da Ros T., Spalluto G., Prato M. Biological applications of fullerene derivatives: a brief overview. Croat Chem Acta 2001;74:743–55.

25. Da Ros T. Twenty Years of Promises: Fullerene in Medicinal Chemistry. In.: Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes. Series: Carbon Materials: Chemistry and Physics, Vol. 1, 2008. Pp. 1–21.

26. Bakry R., Vallant R.M., Najam-ul-Haq M. et al. Medicinal applications of fullerenes. Int J Nanomed 2007;4:639–49.

27. Satoh M., Takayanagi I. Pharmacological Studies on Fullerene (C60), a Novel Carbon Allotrope, and Its Derivatives. J Pharmacol Sci 2006;100:513–8.

28. Chawla P., Chawla V., Maheshwari R., Saraf A. Fullerenes: from carbon to nanomedicine. Mini Reviews in Med Chem 2010;10:662–77.

29. Partha R., Conyers J.L. Biomedical applications of functionalized fullerenebased nanomaterials. Int J Nanomed 2009;4:261–75.

30. Yan L., Zhao F., Li S. et al. Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes. Nanoscale 2011;3:362–82.

31. Parveen S., Misra R., Sahoo S.K. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 2012;8(2):147–66.

32. Huh A.J., Kwon Y.J. «Nanoantibiotics»: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 2011;7:128–45.

33. Койфман О.И., Мамардашвили Н.Ж., Антипин И.С. Синтетические рецепторы на основе порфиринов и их конъюгатов с каликс[4]аренами. М.: Наука, 2006.

34. Satake A., Kobuke Y. Dynamic supramolecular porphyrin system. Tetrahedron 2005;61:13–41.

35. Tykhomyrov A.A., Nedzvetsky V.S., Klochkov V.K., Andrievsky G.V. Nanostructures of hydrated C60 fullerene (C60HyFn) protect rat brain against alcohol impact and attenuate behavioral impairments of alcoholized animals. Toxicology 2008;246:158–65.

36. Buseck P.R. Geological fullerenes: review and analysis. Earth Planet Sci Lett 2002;203:781–92.

37. Shinohara N., Gamo M., Nakanishi J. Fullerene C60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level. Toxicol Sci 2011;123:576–89.